...disagree with [Dew] that that is the intention of [AIM2CERV] trial.
You’re misrepresenting my post. I did not assert that ADXS’ intention in selecting the adjuvant setting for phase-3 was, in fact, shady. Moreover, I found the reply by ‘glbeaty’ in #msg-133262496 persuasive.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”